Profile
Denis Drygin is the founder of Pimera, Inc. which was founded in 2013.
He held the title of Vice President-Research & Development from 2013 to 2020.
Dr. Drygin also held the position of Vice President-Biology at Cylene Pharmaceuticals, Inc. He was the Chief Scientific Officer at Regulus Therapeutics, Inc. from 2020 to 2022.
Dr. Drygin has a graduate and doctorate degree from the University of Massachusetts and undergraduate and graduate degrees from Moscow State University Lomonosov.
Former positions of Denis Drygin
| Companies | Position | End |
|---|---|---|
| REGULUS THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2022-11-28 |
Pimera, Inc.
 Pimera, Inc. Financial ConglomeratesFinance Pimera, Inc. provides investment services. The company is headquartered in San Diego, CA. | Founder | 2020-07-30 |
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Training of Denis Drygin
| University of Massachusetts | Doctorate Degree |
| Moscow State University Lomonosov | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| REGULUS THERAPEUTICS INC. | Health Technology |
| Private companies | 2 |
|---|---|
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Health Technology |
Pimera, Inc.
Pimera, Inc. Financial ConglomeratesFinance Pimera, Inc. provides investment services. The company is headquartered in San Diego, CA. | Finance |
- Stock Market
- Insiders
- Denis Drygin